Tizanidine Tablet
Product Images NDC 51655-740

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 51655-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 740 26)

Label for Tizanidine Tablets USP 4 mg containing 90 tablets, manufactured by Northwind Health Company, LLC. The label states storage instructions, dosage form as tablet for oral use, and a note that the tablets are not interchangeable with Tizanidine capsules. It includes the NDC 51655-740-26 and various manufacturing codes.*

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure of tizanidine shown as a two-dimensional molecular diagram with labeled atoms including chlorine, nitrogen, sulfur, and hydrogen.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A pharmacokinetic curve showing plasma Tizanidine concentration (ng/mL) over time (hours) from dosing up to 24 hours. The graph compares 4 mg Tizanidine tablets and capsules with and without food, illustrating differences in plasma levels post-dose.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

This line graph depicts the improvement in Ashworth Score over six hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis measures the improvement score, and error bars indicate variability at each time point.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A line graph depicting improvement in Ashworth Score over time for Tizanidine and placebo groups. The x-axis shows study time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis shows improvement scores from -6 to 2. Tizanidine (mean dose 28.8 mg) is represented by squares showing greater improvement compared to placebo, represented by circles.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.